New chairman will select the next CEO of Novozymes
Novozymes has not performed satisfactorily, says the new chairman, who has been given the task of selecting Peder Holk Nielsen's future replacement. The process will be long, yet the main shareholder remains optimistic.
The multinational commodity trader navigated through a turbulent market in fiscal 2022, which ended in September, but nonetheless closed the year with a record result. Challenging conditions will carry on into 2023.
Serious dissatisfaction is emanating from European capitals regarding the Energy Charter Treaty for protecting fossil energy investments, thus prompting the EU Commission to assess its options for a collective exit.